Hemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyAn actualiMSCupdateWe haveenough cashto go wellinto 2023We willhaveexclusivityWe intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"I/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeMino-WrapNot manycompaniesthis size with2 late stageassetsHemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyAn actualiMSCupdateWe haveenough cashto go wellinto 2023We willhaveexclusivityWe intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"I/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeMino-WrapNot manycompaniesthis size with2 late stageassets

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Hemorrhoids is a $2B market
  2. Myron Holubiak and I founded a private company in 2013
  3. I'm a shareholder myself
  4. I won't dilute shareholders
  5. We expect to finish the Mino-Lok trial this year
  6. Insiders invested $26.5m
  7. Only biotech with 2 Myron's on the leadership team
  8. Mino-Lok is our lead asset
  9. I/ONTAK's potential market is >$300m
  10. Mino-Lok potential market >$1B
  11. There are no FDA approved drugs to treat hemorrhoids
  12. We had a phase 2b trial with 100% efficacy
  13. An actual iMSC update
  14. We have enough cash to go well into 2023
  15. We will have exclusivity
  16. We intend to submit a BLA in 2H 2022
  17. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  18. We will open up international sites for Mino-Lok trial
  19. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  20. I/ONTAK is our lead asset
  21. Our Halo-Lido trial will have final patient by end of 2022
  22. I/ONTAK was the best deal I ever made
  23. Mino-Wrap
  24. Not many companies this size with 2 late stage assets